AI assistant
INSMED Inc — Director's Dealing 2025
Jan 11, 2025
30150_dirs_2025-01-10_de58f867-e826-47e9-9ea5-60e8bf4fce52.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-01-07
Reporting Person: Bonstein Sara (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-07 | Common Stock | S | 3470 | $65.70 | Disposed | 114736 | Direct |
| 2025-01-08 | Common Stock | S | 1464 | $66.05 | Disposed | 113272 | Direct |
| 2025-01-08 | Common Stock | A | 6657 | — | Acquired | 119929 | Direct |
| 2025-01-10 | Common Stock | S | 1066 | $63.72 | Disposed | 118863 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | Stock Option (right to buy) | $65.72 | A | 31930 | Acquired | 2035-01-08 | Common Stock (31930) | Direct |
Footnotes
F1: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: This is the weighted average sales price representing 3,470 shares sold at prices ranging from $65.69 to $65.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: Includes 725 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F4: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
F5: Each RSU was granted on January 8, 2025 for no consideration.
F6: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.